Catalyst Wire Dossier Catalyst Wire Dossier

Octreotide (LF-PB) extended-release

octreotide · Chemi S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octreotide (LF-PB) extended-release, covering 2014-07-29 to 2014-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea [Phase 2]

See pricing